â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

More documents

Recommendations

Info

CHIEF EXECUTIVE OFFICER´s REPORTfrom <strong>Nycomed</strong>’s strong product sourcing activities in the Nordic region. Oy LeirasFinland Ab will be the fifth largest pharmaceutical company in Finland, and wehave high expectations for this joint venture in the future.Recognising that we are leaving a successful year behind us, we are already wellinto the challenges of 2001, well equipped with the best possible intellectualcapital and with great enthusiasm to pursue our strategy.Håkan Björklund, CEO–10–
SHAREHOLDERSThe following shareholders hold shares with a face value of at least 5% of theshare capital:<strong>Nycomed</strong> Amersham Benelux BV, Eindhoven, HollandNordic Capital III Alpha, L.P., Jersey, Channel IslandsNordic Capital III Beta, L.P., Jersey, Channel IslandsInvestment AB Bure, Göteborg, SwedenAllmänna Pensionsfonden Sjätte Fondstyrelsen, Göteborg, Sweden–11–
Page 2: CONTENT ANNUAL REPORT3 This is Nyco
Page 6 and 7: KEY FIGURESDKK million 2000 1999 *)
Page 8 and 9: CHAIRMAN`s REPORTThe Board is very
Page 10 and 11: CHIEF EXECUTIVE OFFICER´s REPORTA
Page 14 and 15: BOARD OF DIRECTORS1092865131171241
Page 16 and 17: MANAGEMENTThe management group in N
Page 18 and 19: BUSINESS DESCRIPTIONNYCOMED MARKETS
Page 26 and 27: BUSINESS DESCRIPTIONMAIN PRODUCTSC
Page 28 and 29: BUSINESS DESCRIPTIONMAIN PRODUCTSTa
Page 30 and 31: BUSINESS DESCRIPTIONMAIN PRODUCTSNy
Page 32 and 33: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 34 and 35: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 36 and 37: BUSINESS DESCRIPTIONQUALITY ASSURAN
Page 38 and 39: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 40 and 41: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 42 and 43: ACCOUNTSAUDITOR`s REPORT-40-
Page 44 and 45: ACCOUNTSACCOUNTING PRINCIPLESThe re
Page 46 and 47: ACCOUNTSACCOUNTING PRINCIPLESReceiv
Page 48 and 49: ACCOUNTSCONSOLIDATED BALANCE SHEETN
Page 50 and 51: ACCOUNTSCONSOLIDATED ACCOUNTS NOTES
Page 56 and 57: ACCOUNTSPARENT COMPANY PROFIT AND L
Page 58 and 59: ACCOUNTSPARENT COMPANY BALANCE SHEE
Page 60 and 61: ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 62 and 63:
ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 64 and 65:
ACCOUNTSOVERVIEW OF SUBSIDIARIESPar
Page 66 and 67:
NYCOMED GROUP STRUCTURELEGAL STRUCT
Page 68 and 69:
GermanyNycomed Pharma GmbHFraunhofe
show all

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH